09/04/2015 - 10:53am

The Food and Drug Administration this week approved expanded labeling for Janssen Biotech’s rheumatoid arthritis treatment Simponi Aria (golimumab for infusion).

09/04/2015 - 10:23am

AstraZeneca on Thursday announced that the Food and Drug Administration approved Brilinta (ticagrelor) tablets at a 60 mg dose for patients with a history of heart attack beyond the first year.

09/03/2015 - 9:01am

California state Sen. Jeff Stone, a former independent pharmacist himself, had one message for independent pharmacists during the McKesson ideaShare 2015 Public Policy session in San Diego — don’t just vote, get involved.

08/31/2015 - 2:31pm

The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.

08/28/2015 - 11:01am

The Food and Drug Administration has a new diabetes treatment developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co.

08/28/2015 - 10:49am

Vermont on Friday became the last state in the nation to legalize electronic prescriptions for controlled substances — a measure that many states have adopted as a way to combat the abuse of controlled substances and prevent individuals from resorting to fraudulent paper prescriptions.

08/24/2015 - 4:47pm

The National Association of Chain Drugs Stores celebrated Albertsons/Safeway and Kinney Drugs for the companies’ political advocacy and grassroots activities at NACDS Total Store Expo, Friday evening at the NACDS Political Involvement reception.

08/23/2015 - 6:37pm

NACDS president and CEO Steve Anderson discusses the NACDS RxImpact grassroots advocacy program, which can serve as a resource for pharmacy professionals to learn how to engage and educate lawmakers about key pharmacy issues.

08/22/2015 - 5:17pm

“A profound, and likely irreversible, impact on the business of health care.” That’s the effect the Patient Protection and Affordable Care Act already has had in the five years since its passage and enactment into law, PricewaterhouseCoopers said.